Prevention of hospital pathogen biofilm formation by antimicrobial peptide KWI18

Microb Pathog. 2022 Nov:172:105791. doi: 10.1016/j.micpath.2022.105791. Epub 2022 Sep 20.

Abstract

This study investigated the antimicrobial and antibiofilm activity of KWI18, a new synthetic peptide. KWI18 was tested against planktonic cells and Pseudomonas aeruginosa and Candida parapsilosis biofilms. Time-kill and synergism assays were performed. Sorbitol, ergosterol, lipid peroxidation, and protein oxidation assays were used to gain insight into the mechanism of action of the peptide. Toxicity was evaluated against erythrocytes and Galleria mellonella. KWI18 showed antimicrobial activity, with minimum inhibitory concentration (MIC) values ranging from 0.5 to 10 μM. KWI18 at 10 × MIC reduced P. aeruginosa and C. parapsilosis biofilm formation and cell viability. Time-kill assays revealed that KWI18 inhibited the growth of P. aeruginosa in 4 h and that of C. parapsilosis in 6 h. The mechanism of action was related to ergosterol as well as induction of oxidative damage in cells and biofilms. Furthermore, KWI18 demonstrated low toxicity to erythrocytes and G. mellonella. KWI18 proved to be an effective antibiofilm agent, opening opportunities for the development of new antimicrobials.

Keywords: Antibiofilm; Computational design; Peptide antimicrobial.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Antimicrobial Peptides*
  • Biofilms
  • Ergosterol / pharmacology
  • Hospitals
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa
  • Sorbitol / pharmacology

Substances

  • Antimicrobial Peptides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Ergosterol
  • Sorbitol